This article examines the features and applications of Trioctylphosphine Oxide, 99% TOPO including the physical and chemical properties supplied by Strem Chemicals
http://www.azonano.com/article.aspx?ArticleID=2874 | 13 May 2011
This case study compares dynamic light scattering to other methods such as transmission electron microscopy and x-ray diffraction for the determination of particle size for Cadmium Selenide...
http://www.azonano.com/article.aspx?ArticleID=1098 | 20 Jan 2005
Atomic force microscopes (AFMs) use a piezoelectric crystal to actuate the positioning scanner. Creep and hysteresis errors however limit the capability of measuring the sample topography. This...
http://www.azonano.com/article.aspx?ArticleID=2990 | 13 Mar 2012
The Centre of Excellence in Metrology for Micro and Nano Technologies (CEMMNT) provides access to equipment and expertise to accelerate product commercialisation. This article examines Wafer Crystal...
http://www.azonano.com/article.aspx?ArticleID=2062 | 12 Feb 2008
FRT presents a new profilometer at this year's CONTROL 2009 in Stuttgart.
The optical profiler
has been optimized for the non-destructive measurement of surfaces. The MicroSpy
http://www.azonano.com/news.aspx?newsID=11223 | 30 Apr 2009
Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that CRLX101 has achieved its primary efficacy endpoint in an ongoing single-arm Phase 2...
http://www.azonano.com/news.aspx?newsID=29151 | 15 Jan 2014
Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced the publication of translational data on the company's lead candidate, CRLX101, currently in...
http://www.azonano.com/news.aspx?newsID=28255 | 11 Sep 2013
Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, President and Chief Executive Officer, will present at the 14th Annual Needham...
http://www.azonano.com/news.aspx?newsID=32570 | 16 Apr 2015
Crystalline nanoparticle arrays and superlattices can be synthesized with perfectly defined geometries using appropriate electrostatic, hydrogen bonding or biological recognition interactions.
http://www.azonano.com/article.aspx?ArticleID=3217 | 26 Feb 2013
Cerulean Pharma Inc. today announced that the U.S. Food and Drug Administration, or FDA, has granted orphan drug designation to CRLX101 for the treatment of ovarian cancer.
Cerulean is exploring...
http://www.azonano.com/news.aspx?newsID=32859 | 27 May 2015